Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis

Table 2

Laboratory markers by definitive diagnosis in SIRS and non-SIRS patients.

Laboratory findings	Non-SIRS group; Median (5–95%)	SIRS group (5–95%)
		Untreated	6 h reexamination	24 h reexamination
Presepsin (pg/mL)	178 (70–312)	452 (129–880)	584 (154–1331)	660 (190–1705)	<0.001^a,b,c,e, 0.009^d, 0.26^f
PCT (ng/mL)	0.172 (0.017–1.215)	0.973 (0.341–4.794)	1.425 (0.698–9.716)	1.864 (0.712–15.392)	<0.001^a,b,c,d,e, 0.005^f
CRP (mg/L)	6.2 (1.8–9.7)	15.9 (4.9–36.5)	28.4 (7.1–64.2)	55.2 (13.2–82.5)	<0.001^a,b,c,d,e, 0.003^f

Untreated in SIRS group versus non-SIRS group; ^b6 h reexamination in SIRS group versus non-SIRS; ^c24 h reexamination in SIRS group versus non-SIRS group; ^duntreated versus 6 h reexamination; ^euntreated versus 24 h reexamination; ^f6 h reexamination versus 24 h reexamination.